Beatrice Albertini
Overview
Explore the profile of Beatrice Albertini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
473
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bertoni S, Albertini B, Passerini N
Int J Pharm
. 2024 Dec;
669():125030.
PMID: 39645060
Polyoxylglycerides-based solid mixtures, commercially known as Gelucire®, are excipients commonly used for bioavailability improvement of poorly water-soluble drugs. However, their effect on solutions containing hydrophobic drugs above crystalline solubility has...
2.
Di Filippo M, Dolci L, Bonvicini F, Sparla F, Gentilomi G, Panzavolta S, et al.
Sci Rep
. 2024 Sep;
14(1):22053.
PMID: 39333225
Snail secretion is a complex mixture of several components, including proteins, glycoproteins, mucopolysaccharides and smaller molecules. Its growing use in nutraceutical, cosmetic and biomedical applications, as well as a component...
3.
Albertini B, Bertoni S, Nucci G, Botti G, Abrami M, Sangiorgi S, et al.
Int J Pharm
. 2024 Jul;
661:124417.
PMID: 38964489
Benznidazole (BNZ) serves as the primary drug for treating Chagas Disease and is listed in the WHO Model List of Essential Medicines for Children. Herein, a new child-friendly oral BNZ...
4.
Bertoni S, Simone E, Sangiorgi S, Albertini B, Passerini N
Eur J Pharm Sci
. 2023 Nov;
192:106650.
PMID: 37995834
This study investigates the correlation between the structural and release properties of solid lipid microparticles (MPs) of tristearin containing 5 % w/w of four different liquid additives used as crystal...
5.
Bertoni S, Albertini B, Ronowicz-Pilarczyk J, Passerini N
Eur J Pharm Biopharm
. 2023 Jul;
190:171-183.
PMID: 37517450
The aim of this study is to investigate the potential of hybrid polymer-lipid microparticles with a biphasic structure (b-MPs) as drug delivery system. Hybrid b-MPs of Compritol®888 ATO as main...
6.
Albertini B, Bertoni S, Sangiorgi S, Nucci G, Passerini N, Mezzina E
Int J Pharm
. 2023 Feb;
634:122696.
PMID: 36758882
Recently, Natural Deep Eutectic Solvents (NaDES) have emerged as potential solvents for boosting drug bioavailability. In this work, the mechanism of solubility enhancement of some APIs belonging to BCS class...
7.
Bertoni S, Albertini B, Passerini N
Int J Pharm
. 2023 Jan;
632:122576.
PMID: 36596317
Hydrophilic semicrystalline carriers represent an alternative to amorphous polymers due to their low melting temperature, useful for the production of solid dispersions (SDs) by melting-based technologies. This research aims to...
8.
Di Filippo M, Di Matteo V, Dolci L, Albertini B, Ballarin B, Cassani M, et al.
Nanomaterials (Basel)
. 2022 Oct;
12(19).
PMID: 36234575
The development of green, low cost and sustainable synthetic routes to produce metal nanoparticles is of outmost importance, as these materials fulfill large scale applications in a number of different...
9.
Bertoni S, Albertini B, Ronowicz-Pilarczyk J, Calonghi N, Passerini N
Pharmaceutics
. 2022 Jan;
14(1).
PMID: 35056953
Lipid-based biphasic microparticles are generally produced by long and complex techniques based on double emulsions. In this study, spray congealing was used as a solvent-free fabrication method with improved processability...
10.
Bertoni S, Hasa D, Albertini B, Perissutti B, Grassi M, Voinovich D, et al.
Drug Deliv Transl Res
. 2022 Jan;
12(8):1843-1858.
PMID: 34988827
In the last decades, Green Chemistry has been gaining widespread attention within the pharmaceutical field. It is thus very important to bring more sustainable approaches into the design and manufacture...